TB-500 + BPC-157 (5 mg) Stack
TB-500 + BPC-157 (5 mg Stack) combines two of the most extensively researched peptides in connective-tissue and injury-recovery studies. TB-500 (Thymosin Beta-4 fragment) demonstrates systemic effects on cell migration, angiogenesis, and tissue remodeling, while BPC-157 (Body Protection Compound) is explored for its localized support of tendon, ligament, gut, and soft-tissue integrity. Together, they form a synergistic research model for evaluating coordinated repair and regeneration pathways.
Quick Overview
- Research Goal: Tissue repair and recovery modeling
 - Cycle Length: 4 – 6 weeks (extendable as needed)
 - Administration: Subcutaneous injection — rotate sites
 - Important: Do not mix peptides in the same syringe
 
Research Snapshot
TB-500 (Thymosin Beta-4 fragment): studied for its influence on actin regulation, endothelial migration, and wound-healing kinetics.
BPC-157 (Body Protection Compound): gastric-derived peptide fragment studied for maintaining gastrointestinal lining, angiogenesis, and tendon-to-bone healing processes.
Stack rationale: TB-500 acts systemically; BPC-157 supports localized repair — combined use allows exploration of complementary recovery mechanisms.
Potential Research Observations
- Enhanced muscle, tendon, and ligament regeneration signals
 - Improved connective-tissue resilience and flexibility
 - Increased angiogenic and collagen-deposition activity
 - Faster structural recovery in injury-response models
 
Reference Sampling Protocol (Educational)
| Compound | Phase | Reference Amount | Frequency | Duration | 
|---|---|---|---|---|
| TB-500 | Standard | 5 mg/week → 2.5 mg per injection | 2 × weekly | Weeks 1–6 | 
| TB-500 | Advanced | 10 mg/week → 5 mg per injection | 2 × weekly | Weeks 1–6 | 
| BPC-157 | Standard | 500 mcg/day (single dose) | Daily | Weeks 1–2 | 
| BPC-157 | Standard continued | 250 mcg/day (single dose) | Daily | Weeks 3–4 | 
| BPC-157 | Advanced | 750 mcg/day (split AM/PM) | 2 × daily | Weeks 1–2 | 
| BPC-157 | Advanced continued | 500 mcg/day (single dose) | Daily | Weeks 3–4 | 
Reconstitution Guide (Both Peptides)
- Draw the required bacteriostatic water into a sterile syringe.
 - Inject slowly down the vial wall to minimize foaming.
 - Gently swirl until dissolved — avoid vigorous shaking.
 - Label vials with concentration and reconstitution date.
 
Standard Reconstitution Ratios
- TB-500 (5 mg vial): + 2 mL bac water → 2.5 mg/mL (1 unit ≈ 0.025 mg)
 - BPC-157 (5 mg vial): + 2 mL bac water → 2.5 mg/mL (1 unit ≈ 0.025 mg)
 
Advanced Reconstitution Ratios
- TB-500: + 1 mL bac water → 5 mg/mL (1 unit ≈ 0.05 mg)
 - BPC-157: + 1 mL bac water → 5 mg/mL (1 unit ≈ 0.05 mg)
 
Storage & Handling
- Lyophilized: Store in a cool, dark environment below 25 °C.
 - Reconstituted: Refrigerate (2 – 8 °C), protect from light, and use within 30 days.
 - Do not freeze reconstituted solutions.
 
What’s in the Box (4-Week Standard Cycle)
- TB-500: 4 × 5 mg vials (20 mg total)
 - BPC-157: 2 × 5 mg vials (10 mg total)
 - Bacteriostatic water supply for reconstitution
 
Why Choose EU Pharmaceuticals?
EU Pharmaceuticals research-grade peptides are verified by HPLC and Mass Spectrometry for purity and molecular identity. Each vial is produced under controlled conditions to ensure reproducibility across experiments investigating cell-migration, repair, and angiogenic pathways.
For laboratory, educational, and research use only. Not for human or veterinary ingestion or therapeutic application. No medical or performance claims are made or implied. Buyer assumes responsibility for lawful handling and regulatory compliance.
TB-500 + BPC-157 (5 mg) Stack
- 
              
$240.00
 


